Guides
Tender results, volumes and holders, explained
Short, practical guides to the questions commercial teams ask about European pharmaceutical tenders: how to find who won, how to estimate volumes that are not stated, how licence holders differ from manufacturers, and what to look for in tender intelligence software.
How to Choose Pharma Tender Intelligence Software
Choose on what happens after a tender closes. The useful questions are whether it shows the winner and the published bid prices per strength, separates stated from...
Read the guide GuideHow to Find Who Won a Pharmaceutical Tender in Europe
The winner appears in the buyer's award notice or award decision, published after the standstill period. Many buyers name the winner but not every bidder's price,...
Read the guide GuideHow to Estimate Tender Volumes When They Are Not Stated
Treat any volume in a tender as a starting point. Many buyers publish estimates, frame volumes as maximums, or leave them out. A better estimate combines the stated...
Read the guide GuideLicence Holder vs Manufacturer: Who Really Makes a Generic?
The marketing authorisation holder is the company legally responsible for a medicine in a market. The manufacturer is the company that makes and releases it. For...
Read the guide GuideTender Visibility for Partner-Led Generics Manufacturers
When partners hold the licences and bid in tenders, the manufacturer sees the outcome only in its order book. Mapping each partner's products and markets to tenders,...
Read the guide GuideHow Pharmaceutical Tenders Work in Europe
European medicines are tendered by hospitals, hospital purchasing groups, regional or national central bodies and, in some countries, health insurers. Each tender is...
Read the guide GuideAward Notice Without a Winner or Price: Why It Happens
EU rules require an award notice within 30 days of signing a contract, but let buyers withhold details whose release would harm commercial interests or fair...
Read the guide GuideWhy Did We Lose the Tender? Debriefs and Standstill Rules
Under EU rules, a rejected bidder can ask the buyer in writing for the reasons for rejection and, if its offer was admissible, the characteristics and relative...
Read the guide GuideHow to Price a Generic Tender Bid
Start from your own floor, the lowest price you can supply at, then look at what actually won before for the same molecule, buyer type and lot structure. Adjust for...
Read the guide GuideMedicine Framework Agreements: Call-Offs, Mini-Competitions
A framework agreement sets prices and terms with one or more suppliers for up to four years, and the buyer orders during that time. With one supplier, orders go...
Read the guide ExplainerCritical Medicines Act: What Changes in Medicine Tenders
The Critical Medicines Act is an EU regulation agreed provisionally in 2026 and not yet in force. For medicines on the EU list of critical medicines, it would push...
Read the guide ResourceCPV Codes for Medicines: the 33600000 Group Explained
Medicine tenders in the EU are classified under CPV 33600000 (pharmaceutical products), split into subgroups that broadly follow the ATC therapeutic groups, such as...
Read the guide ResourceMedicine Buyers in Europe: Purchasing Bodies by Country
In most European countries, hospital medicines are bought by regional or national purchasing bodies and hospital groups. Germany and the Netherlands add health...
Read the guide MedTechMedical Device Tenders in Europe: Buyers, Criteria, Results
Medical devices, diagnostics and consumables are tendered by hospitals, hospital groups and central purchasing bodies across Europe, usually under CPV group 33100000...
Read the guideLooking for a single term? Browse the tender glossary or read how each market tenders
Prefer to see it on your own data?
Book a short demo and we will answer these questions for your molecules and markets.